Prostate Cancer Reports


Volume 2 Supplement 1
 
January 2014
Home > Prostate Cancer Reports > Volume 2 - Year 2014 > Supplement 1, January 2014

CONTENTS



Diagnosis and evaluation
Etiology and pathogenesis
Integrative medicine
Metastasis
Nomograms
Oncological outcomes
Statins
Survival
Treatment
Treatment comparison




Almeida GL, Musi G, Mazzoleni F, Matei DV, Brescia A, Detti S, de Cobelli O.
Intraoperative frozen pathology during robot-assisted laparoscopic radical prostatectomy: can ALEXIS™ trocar make it easy and fast?
J Endourol. 2013 Oct;27(10):1213-7. doi: 10.1089/end.2012.0645. Epub 2013 Aug 30.
Abstract | Related citations


Matei DV, Renne G, Pimentel M, Sandri MT, Zorzino L, Botteri E, De Cicco C, Musi G, Brescia A, Mazzoleni F, Tringali V, Detti S, de Cobelli O.
Neuroendocrine differentiation in castration-resistant prostate cancer: a systematic diagnostic attempt.
Clin Genitourin Cancer. 2012 Sep;10(3):164-73. doi: 10.1016/j.clgc.2011.12.004. Epub 2012 Mar 7.
Abstract | Related citations


Petralia G, Alessi S, Alconchel A, Summers P, Musi G, Matei V, De Cobelli O, Renne G, Bellomi M.
Anterior prostatic tumours are difficult to diagnose without MRI.
Ecancermedicalscience. 2012;6:252. doi: 10.3332/ecancer.2012.252. Epub 2012 Apr 24.
Abstract | Full text | Related citations


Rocco B, de Cobelli O, Leon ME, Ferruti M, Mastropasqua MG, Matei DV, Gazzano G, Verweij F, Scardino E, Musi G, Djavan B, Rocco F.
Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report.
Eur Urol. 2006 May;49(5):827-33. Epub 2006 Jan 6.
Abstract | Related citations

ETIOLOGY AND PATHOGENESIS


Delbue S, Matei DV, Carloni C, Pecchenini V, Carluccio S, Villani S, Tringali V, Brescia A, Ferrante P.
Evidence supporting the association of polyomavirus BK genome with prostate cancer.
Med Microbiol Immunol. 2013 Dec;202(6):425-30. doi: 10.1007/s00430-013-0304-3. Epub 2013 Jul 3.
Abstract | Related citations



Brunetti J.
Article Commentary -- "A Randomized Phase II Study of Pomegranate Extract for Men with Rising PSA Following Initial Therapy for Localized Prostate Cancer".
Society for Integrative Oncology. March, 2013
Abstract | Full text


Carducci MA, Paller CJ, Wozniak P, Sieber P, Greengold R, Stockton B, Hertzman B, Roper R, Liker H, Ye X, The Pom Wonderful Working Group.
A phase II study of pomegranate extract for men with rising prostate-specific antigen following primary therapy.
2011 Genitourinary Cancers Symposium, J Clin Oncol 29: 2011 (suppl 7; abstr 11).
Abstract



Memorial Sloan Kettering Cancer center
Pomegranate
MSKCC Cancer & Treatment, Integrative Medicine. Last updated: August 14, 2013.
Abstract | Full text



Nguyen JY, Major JM, Knott CJ, Freeman KM, Downs TM, Saxe GA.
Adoption of a plant-based diet by patients with recurrent prostate cancer.
Integr Cancer Ther. 2006 Sep;5(3):214-23.
Abstract | Related citations


Paller CJ, Ye X, Wozniak PJ, Gillespie BK, Sieber PR, Greengold RH, Stockton BR, Hertzman BL, Efros MD, Roper RP, Liker HR, Carducci MA.
A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer.
Prostate Cancer Prostatic Dis. 2013 Mar;16(1):50-5. doi: 10.1038/pcan.2012.20. Epub 2012 Jun 12.
Abstract | Full text | Related citations



Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A.
Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.
Clin Cancer Res. 2006 Jul 1;12(13):4018-26.
Abstract | Full text | Related citations


Pantuck AJ, Zomorodian N, Belldegrun AS.
Phase-II Study of pomegranate juice for men with prostate cancer and increasing PSA.
Curr Urol Rep. 2006 Jan;7(1):7.
Abstract | Related citations


Saxe GA, Major JM, Nguyen JY, Freeman KM, Downs TM, Salem CE.
Potential attenuation of disease progression in recurrent prostate cancer with plant-based diet and stress reduction.
Integr Cancer Ther. 2006 Sep;5(3):206-13.
Abstract | Full text | Related citations



Stenner-Liewen F, Liewen H, Cathomas R, Renner C, Petrausch U, Sulser T, Spanaus K, Seifert HH, Strebel RT, Knuth A, Samaras P, Müntener M.
Daily Pomegranate Intake Has No Impact on PSA Levels in Patients with Advanced Prostate Cancer - Results of a Phase IIb Randomized Controlled Trial.
J Cancer. 2013 Aug 29;4(7):597-605. doi: 10.7150/jca.7123. eCollection 2013.
Abstract | Full text | Related citations



Wang L, Ho J, Glackin C, Martins-Green M.
Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis.
Transl Oncol. 2012 Oct;5(5):344-55. Epub 2012 Oct 1.
Abstract | Full text | Related citations

METASTASIS



Messina M, Ricci F, Spina B, Boccardo F.
Single skull metastasis 15 years after primary treatment of prostate cancer and with undetectable PSA levels: a case report and review of the literature.
Tumori. 2013 Sep-Oct;99(5):220e-4e. doi: 10.1700/1377.15319.
Abstract | Related citations


Slovin SF, Wilton AS, Heller G, Scher HI.
Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy.
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8669-73.
Abstract | Full text | Related citations

Nomograms



Briganti A, Joniau S, Gontero P, Abdollah F, Passoni NM, Tombal B, Marchioro G, Kneitz B, Walz J, Frohneberg D, Bangma CH, Graefen M, Tizzani A, Frea B, Karnes RJ, Montorsi F, Van Poppel H, Spahn M.
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.
Eur Urol. 2012 Mar;61(3):584-92. doi: 10.1016/j.eururo.2011.11.043. Epub 2011 Dec 2.
Abstract | Related citations



Suardi N, Porter CR, Reuther AM, Walz J, Kodama K, Gibbons RP, Correa R, Montorsi F, Graefen M, Huland H, Klein EA, Karakiewicz PI.
A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
Cancer. 2008 Mar 15;112(6):1254-63. doi: 10.1002/cncr.23293.
Abstract | Full text | Related citations



Biochemical recurrence



Kontraros M, Varkarakis I, Ntoumas K, Deliveliotis C.
Pathological characteristics, biochemical recurrence and functional outcome in radical prostatectomy patients on statin therapy.
Urol Int. 2013;90(3):263-9. doi: 10.1159/000346751. Epub 2013 Mar 20.
Abstract | Related citations


Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.
Abstract | Related citations




Hamilton RJ, Banez LL, Aronson WJ, Terris MK, Platz EA, Kane CJ, Presti JC Jr, Amling CL, Freedland SJ.
Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
Cancer. 2010 Jul 15;116(14):3389-98. doi: 10.1002/cncr.25308.
Abstract | Full text | Related citations



Singh S, Singh PP.
Statin a day keeps cancer at bay.
World J Clin Oncol. 2013 May 10;4(2):43-6. doi: 10.5306/wjco.v4.i2.43.
Abstract | Full text | Related citations

Survival




Kibel AS, Ciezki JP, Klein EA, Reddy CA, Lubahn JD, Haslag-Minoff J, Deasy JO, Michalski JM, Kallogjeri D, Piccirillo JF, Rabah DM, Yu C, Kattan MW, Stephenson AJ.
Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.
J Urol. 2012 Apr;187(4):1259-65. doi: 10.1016/j.juro.2011.11.084. Epub 2012 Feb 14.
Abstract | Full text | Related citations

Treatment



Overviews

Aizer AA, Chen MH, Hattangadi J, D'Amico AV.
Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.
BJU Int. 2014 Jan;113(1):43-50. doi: 10.1111/j.1464-410X.2012.11789.x. Epub 2013 Mar 8.
Abstract | Full text | Related citations


First treatment

Jereczek-Fossa BA, Santoro L, Zerini D, Fodor C, Vischioni B, Dispinzieri M, Bossi-Zanetti I, Gherardi F, Bonora M, Caputo M, Vavassori A, Cambria R, Garibaldi C, Cattani F, Matei DV, Musi G, De Cobelli O, Orecchia R.
Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
J Urol. 2013 Jun;189(6):2099-103. doi: 10.1016/j.juro.2013.01.005. Epub 2013 Jan 9.
Abstract | Related citations


Orecchia R, Jereczek-Fossa BA, Ciocca M, Vavassori A, Cambria R, Cattani F, Zerini D, Matei DV, Rocco B, Verweij F, Scardino E, De Cobelli O.
Intraoperative radiotherapy for locally advanced prostate cancer: treatment technique and ultrasound-based analysis of dose distribution.
Anticancer Res. 2007 Sep-Oct;27(5B):3471-6.
Abstract | Full text | Related citations


Rocco B, Jereczek-Fossa BA, Matei DV, Verweij F, Santoro L, Vavassori A, Ospina JC, Cedeira F, Ciocca M, Orecchia R, de Cobelli O.
Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysis.
BJU Int. 2009 Dec;104(11):1624-30. doi: 10.1111/j.1464-410X.2009.08668.x. Epub 2009 Jul 14.
Abstract | Related citations


Second-line-treatment

Alongi F, De Bari B, Campostrini F, Arcangeli S, Matei DV, Lopci E, Petralia G, Bellomi M, Chiti A, Magrini SM, Scorsetti M, Orecchia R, Jereczek-Fossa BA.
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review.
Crit Rev Oncol Hematol. 2013 Dec;88(3):550-63. doi: 10.1016/j.critrevonc.2013.07.009. Epub 2013 Aug 15.
Abstract | Full text | Related citations



Chalasani V, Iansavichene AE, Lock M, Izawa JI.
Salvage radiotherapy following radical prostatectomy.
Int J Urol. 2009 Jan;16(1):31-6. doi: 10.1111/j.1442-2042.2008.02144.x. Epub 2008 Aug 20.
Abstract | Full text | Related citations


Ghadjar P, Zwahlen D, Aebersold DM, Zimmermann F.
Postoperative radiotherapy after radical prostatectomy: indications and open questions.
Prostate Cancer. 2012;2012:963417. doi: 10.1155/2012/963417. Epub 2012 Feb 28.
Abstract | Full text | Related citations
 

Chien CP, Roach M 3rd.
Who, when, where, and how: salvage prostate cancer with radiotherapy.
Oncology (Williston Park). 2010 Jul;24(8):702, 704.
Abstract | Full text | Related citations


Hamstra DA, Michalski JM, Roach M, Sandler HM.
Do not count out external-beam radiation therapy for high-risk prostate cancer.
J Clin Oncol. 2010 Oct 1;28(28):e518-9; author reply e521-e522. doi: 10.1200/JCO.2010.28.9561. Epub 2010 Jul 26.
Abstract | Full text | Related citations



Izawa JI.
Salvage radiotherapy after radical prostatectomy.
Can Urol Assoc J. 2009 Jun;3(3):245-250.
Abstract | Full text


Jacinto AA, Fede AB, Fagundes LA, Salvajoli JV, Castilho MS, Viani GA, Fogaroli RC, Novaes PE, Pellizzon AC, Maia MA, Ferrigno R.
Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy.
Radiat Oncol. 2007 Feb 22;2:8.
Abstract | Full text | Related citations


Jereczek-Fossa BA, Zerini D, Vavassori A, Fodor C, Santoro L, Minissale A, Cambria R, Cattani F, Garibaldi C, Serafini F, Matei VD, de Cobelli O, Orecchia R.
Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy.
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):115-25. doi: 10.1016/j.ijrobp.2008.07.057. Epub 2008 Nov 12.
Abstract | Related citations


Nguyen PL, D'Amico AV.
Deciding which patients to treat with salvage radiotherapy after prostatectomy.
Oncology (Williston Park). 2010 Jul;24(8):705, 711.
Abstract | Full text | Related citations



Peyromaure M, Allouch M, Eschwege F, Verpillat P, Debré B, Zerbib M.
Salvage radiotherapy for biochemical recurrence after radical prostatectomy: a study of 62 patients.
Urology. 2003 Sep;62(3):503-7.
Abstract | Related citations



Quero L, Mongiat-Artus P, Ravery V, Maylin C, Desgrandchamps F, Hennequin C.
Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience.
BMC Cancer. 2008 Jan 29;8:26. doi: 10.1186/1471-2407-8-26.
Abstract | Full text | Related citations



Raldow A, Hamstra DA, Kim S, Yu JB.
Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy.
Oncology (Williston Park). 2010 Jul;24(8):692-700, 702.
Abstract | Full text | Related citations | (Educational article)



Sia M, Pickles T, Morton G, Souhami L, Lukka H, Warde P.
Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting.
Can Urol Assoc J. 2008 Oct;2(5):500-7.
Abstract | Full text | Related citations


Spitaleri G, Matei DV, Curigliano G, Detti S, Verweij F, Zambito S, Scardino E, Rocco B, Nolè F, Ariu L, De Pas T, de Braud F, De Cobelli O.
Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer.
Ann Oncol. 2009 Mar;20(3):498-502. doi: 10.1093/annonc/mdn650. Epub 2009 Jan 12.
Abstract | Full text | Related citations


van der Poel HG, Tillier C, de Blok W, Acar C, van Muilekom EH.
Salvage radiotherapy after robot-assisted laparoscopic radical prostatectomy.
Urology. 2013 Oct;82(4):834-8. doi: 10.1016/j.urology.2013.04.057. Epub 2013 Aug 22.
Abstract | Full text | Related citations


Zampino MG, Verri E, Locatelli M, Curigliano G, Ascione G, Sbanotto A, Rocca A, Verweij F, Matei V, Scardino E, Decobelli O, Goldhirsch A, Nolè F.
Vinorelbine-based chemotherapy in hormone-refractory prostate cancer.
Anticancer Res. 2006 May-Jun;26(3B):2375-80.
Abstract | Full text | Related citations


Zelefsky MJ, Scardino S, Vickers A, Eastham J.
Reply to D.A. Hamstra et al and A.P. Sandhu
JCOvol. 28 no. 28 e521-e522.
Abstract | Full text

TREATMENT COMPARISON



Rocco B, Matei DV, Melegari S, Ospina JC, Mazzoleni F, Errico G, Mastropasqua M, Santoro L, Detti S, de Cobelli O.
Robotic vs open prostatectomy in a laparoscopically naive centre: a matched-pair analysis.
BJU Int. 2009 Oct;104(7):991-5. doi: 10.1111/j.1464-410X.2009.08532.x. Epub 2009 May 5.
Abstract | Full text | Related citations